The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 190.00
High: 190.00
Low: 190.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adoption of Financial Reporting Standard 101

10 Jan 2017 07:00

RNS Number : 7279T
Synectics PLC
10 January 2017
 

 

 

 

10 January 2017

 

Synectics plc

 

Notification to shareholders on parent company financial statements: Adoption of Financial Reporting Standard 101 - Reduced Disclosure Framework

 

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that following the introduction by the Financial Reporting Council ("FRC") of a new UK Generally Accepted Accounting Practice ("UK GAAP") accounting framework for periods commencing on or after 1 January 2015, there is a requirement to prepare its parent company financial statements for its financial year commencing 1 December 2015 on one of the new bases permitted by the FRC.

 

The financial statements for the year ended 30 November 2015 of Synectics plc (the "Company"), as set out on pages 78 to 86 of the 2015 Annual Report, were prepared in accordance with UK GAAP. The 2015 Annual Report is available on the Company's website, www.synecticsplc.com.

 

The Company proposes to adopt FRS 101 "Reduced Disclosure Framework" and to take advantage of the permitted election to the disclosure exemptions allowed under FRS 101 for the year ended 30 November 2016 and thereafter. As a result of taking the available disclosure exemptions permitted under FRS 101, disclosures are expected to follow closely those reported under UK GAAP.

 

The Company's decision to adopt FRS 101 does not require shareholder approval. However, due to the election to take the available disclosure exemptions permitted under FRS 101, the Company is required to notify all shareholders of this election and any shareholder or shareholders holding in aggregate 5 per cent. or more of the total allotted shares in the Company may object. Objections must be served in writing and be delivered to the Company Secretary at the Company's registered office at Studley Point, 88 Birmingham Road, Studley, Warwickshire B80 7AS not later than Tuesday 7 February 2017. A letter will be sent to the Company's shareholders later today.

 

The consolidated financial statements of the Company and its subsidiaries will continue to be prepared in accordance with IFRS as adopted by the EU.

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Paul Webb, Chief Executive

Mike Stilwell, Finance Director

www.synecticsplc.com

email: info@synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

Media enquiries:

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Jane Glover

email: synectics@buchanan.uk.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGMNLLGNZM
Date   Source Headline
24th Apr 202410:00 amRNSResult of AGM
24th Apr 20247:00 amRNSAGM Statement
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.